Patent ID: 9161970
Filing Date: 2015-10-20
Classification: A61K,A61L,A61P,A61Q,C12N,C12Y,Y02A

Abstract:
1. A method for treating a facial wrinkle by administering to the patient a pharmaceutical composition comprising a) a botulinum neurotoxin, b) a serum albumin, wherein the concentration of the serum albumin in the pharmaceutical composition is about 5 μg or less per unit of the botulinum neurotoxin, and c) a viscous carrier comprising a cross-linked hyaluronic acid, wherein said cross-linked hyaluronic acid has a cross-linking density of from 5% to about 10%, wherein the patient's facial wrinkles are alleviated for a longer period of time than they are by administration of a pharmaceutical composition which does not comprise a botulinum neurotoxin.